Laxbene Junior Mit Cola-Geschmack Zur Anwendung Bei Kindern Zwischen 6 Monaten Und 8 Jahren

Macrogol 4000, the active ingredient in Laxbene Junior Mit Cola‑Geschmack Zur Anwendung Bei Kindern Zwischen 6 Monaten Und 8 Jahren, is an osmotic laxative presented as an oral liquid formulation for oral use. It is indicated for the relief of constipation in children from six months up to eight years of age and is flavored with cola to improve palatability.

GNH USA supplies Laxbene Junior Mit Cola‑Geschmack as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide under EU quality standards.

Laxbene Junior, containing macrogol 4000, is used to treat constipation in the pediatric population. - Constipation in infants (6–12 months): softens stools and facilitates regular bowel movements. - Constipation in toddlers (1–3 years): increases intestinal water content to promote easier passage of stool. - Constipation in older children (4–8 years): provides osmotic action that relieves chronic functional constipation.

Macrogol 4000 may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal bloating: feeling of fullness in the abdomen. - Flatulence: increased gas production. - Nausea: mild queasiness. - Diarrhoea: loose stools. - Stomach cramps: intermittent abdominal pain. - Increased thirst: feeling of needing more fluids.

Serious or Rare Side Effects: - Severe dehydration: marked loss of body fluids. - Electrolyte imbalance: abnormal levels of sodium, potassium or other electrolytes. - Allergic reaction: rash, itching, swelling or difficulty breathing. - Intestinal obstruction: worsening constipation or blockage.

When using Laxbene Junior, several precautions should be observed to ensure safe and effective therapy. - Dosage adjustment: tailor the dose to the child’s age, weight and clinical response as directed by a healthcare professional. - Fluid intake: maintain adequate hydration to support the osmotic action of the product. - Electrolyte monitoring: assess electrolyte status during prolonged use, especially in infants. - Avoid in bowel obstruction: do not use if a mechanical blockage of the intestine is suspected. - Store at room temperature: keep the product in its original container, protect from moisture and store below 25 °C.

Macrogol 4000 can interact with certain medicines, affecting either its efficacy or the safety profile of the co‑administered drug.

Major Interactions (Avoid): - Lithium: concurrent use may increase lithium serum concentrations. - Antacids containing magnesium or aluminium: can reduce the laxative effect of macrogol. - Diuretics: may exacerbate electrolyte disturbances when combined with macrogol.

Moderate Interactions (Monitor Closely): - Oral rehydration salts: combined osmotic load may alter fluid balance. - Other laxatives or stool softeners: additive laxative effect can increase risk of diarrhoea.